Cunningham, Kevin P., Clapp, Lucie H., Mathie, Alistair, Veale, Emma L. (2021) The Prostacyclin Analogue, Treprostinil, Used in the Treatment of Pulmonary Arterial Hypertension, is a Potent Antagonist of TREK-1 and TREK-2 Potassium Channels. Frontiers in Pharmacology, 12 . ISSN 1663-9812. (doi:10.3389/fphar.2021.705421) (KAR id:89481)
|
PDF
Publisher pdf
Language: English 
This work is licensed under a Creative Commons Attribution 4.0 International License.
|
|
|
Download (2MB)
Preview
|
Preview |
|
This file may not be suitable for users of assistive technology.
Request an accessible format
|
|
| Official URL: https://doi.org/10.3389/fphar.2021.705421 |
|
| Item Type: | Article |
|---|---|
| DOI/Identification number: | 10.3389/fphar.2021.705421 |
| Subjects: |
Q Science > QP Physiology (Living systems) > QP506 Molecular biology R Medicine > RM Therapeutics. Pharmacology |
| Divisions: | Divisions > Division of Natural Sciences > Medway School of Pharmacy |
| Depositing User: | Alistair Mathie |
| Date Deposited: | 27 Jul 2021 19:17 UTC |
| Last Modified: | 14 Nov 2022 23:12 UTC |
| Resource URI: | https://kar.kent.ac.uk/id/eprint/89481 (The current URI for this page, for reference purposes) |
- Link to SensusAccess
- Export to:
- RefWorks
- EPrints3 XML
- BibTeX
- CSV
- Depositors only (login required):
Altmetric
Altmetric
